Ranbaxy Laboratories Ltd and Nippon Chemiphar (NC) has announced the dissolution of their joint venture Nihon Pharmaceutical Industry Co Ltd (NPI) in Japan. This follows an agreement between the two companies that allows NC to purchase the entire shareholding of its erstwhile partner. Both companies held equal shares in the venture.

 

Following the transaction, NPI will become a wholly owned subsidiary of Nippon Chemiphar. Ranbaxy sold seven generic products through the joint venture in Japan. While these products will continue to be sold through NPI, it may be transitioned to Daiichi Sankyo in the long term.

crackcrack
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...